Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia

Clofarabine (40 mg/m(2)/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m(2)/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (N = 4) and relapsed (N = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myelosuppres...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tse, Eric, Leung, Anskar Y. H., Sim, Joycelyn, Lee, Harold K. K., Liu, Herman S. Y., Yip, Sze-Fai, Kwong, Yok-Lam
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3187852/
https://ncbi.nlm.nih.gov/pubmed/21455604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-011-1223-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados